No need to login to view prices!
|Create new account|
Due to technical maintenance the webshop is closed until January 4th, 2020. We wish you a successful 2021!
LEIDEN April 1, 2020 - BIOKÉ, a business unit of Cell Signaling Technology Europe, announced it has signed a distribution agreement with abc biopply, an innovative and dynamic biotech company, to distribute abc biopply’s 3D CoSeedis™ cell culture technology in the Netherlands, Belgium and Luxembourg (Benelux), effective immediately.
“We cannot wait to bring the novel 3D CoSeedis™ cell co-culture system to our customers in the Benelux," said Robert Hovingh, Sales Manager BIOKÉ. "This unique scaffold-free 3D cell co-culture system from abc biopply is a great tool to allow the formation of spheroidal and non-spheroidal cell aggregates in a highly-reproducible and consistent manner.”
"Our aim is to substantially improve the level of standardization of complex cell biological processes, namely in the area of 3-dimensional cell culture technologies." said abc biopply’s Head of Sales and Operations and Co-owner, Dr. Marco Leu. “We are looking forward to working with the knowledgeable and enthusiastic BIOKÉ team to provide this cutting edge 3D cell culture technology to research labs in the Benelux.”
abc biopply is an innovative and dynamic biotech company headquartered in Solothurn, Switzerland with laboratory and research facilities in Cham, Switzerland. abc biopply devotes its know-how and expertise in complex cell culture technologies to define and validate standardized workflows, technologies and protocols, particularly in 3-dimensional applications. With 3D CoSeedis™, it is at the cutting edge of 3D cell culture technologies and defines a quantum leap in 3-dimensional ex vivo cell biology.
Founded in 2004, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe. BIOKÉ delivers unique and high-performance applications and workflows for genomics, protein analysis and cell biology. In July 2009 Cell Signaling Technology, Inc. (CST) - the market leader in the development of highquality antibody products and technologies - acquired BIOKÉ BV and BIOKÉ became a business unit of Cell Signaling Technology Europe. CST Europe and BIOKÉ hold offices in Leiden, the Netherlands.